HeartBeam Inc (BEAT) - Market Cap to Earnings

Symbol and logo of brand HeartBeam Inc (BEAT)

HeartBeam, Inc. (BEAT) is implementing portable robotics for AI-powered cloud ECG analysis, simplifying rhythm monitoring. The business relies on a scalable software platform that generates recurring subscription revenue via smartphones. Complex patents and FDA certification serve as protection, creating a technological moat. This price chart confirms these data, with the P/E ratio standing at -1.20.

heartbeam.com (BEAT): Price to Earnings Ratio from 07/04/2022 to 11/12/2026

Comprehensive metric breakdowns and analytics for HeartBeam Corp (BEAT)

- share price and expert price forecast:
Price Performance Chart heartbeam.com|BEAT - Analyst Consensus Forecast
- market capitalization indicators:
Market Value HeartBeam, Inc.|BEAT - Enterprise Value
- book value of equity indicators:
Book Value per Share HeartBeam|BEAT - Company Book Value|Market Value to Book Value heartbeam.com|BEAT - Cumulative Company Assets
- debt and solvency information:
Aggregate Debt to Capital HeartBeam, Inc.|BEAT - Long-Term Debt to Capital|Short-Term Debt to Equity HeartBeam Corporation|BEAT - Company Aggregate Debts|Debts to Book Value HeartBeam, Inc.|BEAT - Company Long-Term Debts|Company Short-Term Debts HeartBeam|Quick Liquidity Indicator heartbeam.com
- net income and valuation ratios data:
BEAT - Net Income|Expected Net Income HeartBeam, Inc.|BEAT - P/E Multiple|Market Cap to Projected Earnings HeartBeam Inc|BEAT - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation HeartBeam, Inc.|BEAT - Operating profit EBITDA|Net earnings per share for the last 12 months HeartBeam|BEAT - Net earnings per share for the last 12 months|Year-over-year net earnings per share change for the last twelve months heartbeam.com|BEAT - Earnings growth in current year|Net earnings per share growth forecast for next year HeartBeam, Inc.
Summary company analysis:BEAT (heartbeam.com)
Finished products of HeartBeam Corporation

Fundamental asset screening requires a precise alignment of market capitalization with net income to determine the extent of a security's overvaluation. By analyzing the P/E fluctuations of HeartBeam, Inc. (BEAT), an investor can identify the investment payback ratio, which for HeartBeam, Inc. (BEAT) reflects market expectations regarding the implementation of their breakthrough 3D vector ECGs and real-time AI diagnostics.

Key competitors

REGN: Company Value to Net Income|P/E Multiple IRTC|LNTH - Market Cap to Earnings|P/E Multiple MLYS (Mineralys Therapeutics Inc)|P/E Multiple HeartFlow HTFL|KMTS - Price to Earnings Ratio|Company Value to Net Income ESPR (esperion.com)|AMRN (Amarin) - Price to Earnings Ratio|AVR: Market Price to Net Income Ratio|TNYA (Tenaya) - P/E Multiple|Price to Earnings Ratio CVRX|P/E Multiple MIST|CRDL - Market Cap to Earnings|P/E Multiple TENX (Tenax Therapeutics, Inc.)|P/E Multiple Adagio Medical Holdings, Inc. ADGM|BCDA - Price to Earnings Ratio|Catheter Precision Corporation (VTAK) - Price to Earnings Ratio|ABIO (arcabio.com) - Price to Earnings Ratio|Acasti Pharma Inc. - Company Value to Net Income|AVTE (Aerovate Therapeutics, Inc.) - P/E Multiple|Verve (VERV) - Business Payback Period|Price to Earnings Ratio Windtree Therapeutics (WINT)